Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke - An Italian case-control study

被引:67
作者
Margaglione, M
Seripa, D
Gravina, C
Grandone, E
Vecchione, G
Cappucci, G
Merla, G
Papa, S
Postiglione, A
Di Minno, G
Fazio, VM
机构
[1] IRCCS, Unita Aterosclerosi & Trombosi, I-71013 San Giovanni Rotondo, FG, Italy
[2] IRCCS, Unita Patol Mol, I-71013 San Giovanni Rotondo, FG, Italy
[3] Univ Palermo, Ist Med Interna & Geriatr, Palermo, Italy
[4] Univ Cattolica Sacro Cuore, Rome, Italy
关键词
apolipoprotein E; risk factors; stroke; thrombosis;
D O I
10.1161/01.STR.29.2.399
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The epsilon 4 allele of the apolipoprotein E (apoE) has been related to the occurrence of myocardial infarction, but its association with ischemic stroke is controversial. We have evaluated the relation between apoE alleles and the occurrence of cerebrovascular ischemia. Methods-The apoE epsilon genotypes of 100 patients with a documented history of ischemic stroke without clinically apparent dementia (stroke+) and 108 subjects without such history (stroke-) were determined. The relative frequency of the apoE alleles and genotypes was estimated in 398 healthy subjects aged <40 years h-om the same ethnic background. Results-The frequency of the apoE epsilon 4 allele in stroke+ (0.18 [95% CI, 0.12 to 0.25]) was higher than in stroke-(0.07 [95% CI, 0.03 to 0.12]; P<.001) or in healthy subjects (0.09 [95% CI, 0.07 to 0.12]; P<.001). Carriers of the epsilon 4 allele differed between stroke+ (0.30 [95% CI, 0.19 to 0.42]) and stroke-(0.12 [95% CI, 0.5 to 0.22]; P=.004) or healthy subjects (0.16 [95% CI; 0.12 to 0.22]; P=.015). Accordingly, epsilon 3/epsilon 3 homozygotes were less frequent in stroke+ (0.59 [95% CI, 0.45 to 0.71]) than in stroke-(0.72 [95% CI, 0.59 to 0.82]; P=.063) or in healthy subjects (0.73 [95% CI, 0.67 to 0.78]; P=.01). In a multiple logistic regression analysis, age (P<.03), positive family history (P<.04) and apoE (P<.002) independently contributed to a stroke history, with epsilon 4 carriers exhibiting a higher estimated risk (odds ratio, 5.05). Conclusions-Our data show an association between apoE gene and a personal history of ischemic stroke and support the possibility that the apoE gene is a susceptibility locus for the risk of cerebrovascular ischemic disease.
引用
收藏
页码:399 / 403
页数:5
相关论文
共 43 条
[1]   Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more [J].
Basun, H ;
Corder, EH ;
Guo, Z ;
Lannfelt, L ;
Corder, LS ;
Manton, KG ;
Winblad, B ;
Viitanen, M .
STROKE, 1996, 27 (08) :1310-1315
[2]   EPIDEMIOLOGY OF STROKE [J].
BONITA, R .
LANCET, 1992, 339 (8789) :342-344
[3]  
BRISONI GB, 1996, J NEUROL NEUROSUR PS, V60, P699
[4]   Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults [J].
Cattin, L ;
Fisicaro, M ;
Tonizzo, M ;
Valenti, M ;
Danek, GM ;
Fonda, M ;
DaCol, PG ;
Casagrande, S ;
Pincetti, E ;
Bovenzi, M ;
Baralle, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) :91-94
[5]   APOLIPOPROTEIN-E POLYMORPHISM IN ITALY INVESTIGATED IN NATIVE PLASMA BY A SIMPLE POLYACRYLAMIDE-GEL ISOELECTRIC-FOCUSING TECHNIQUE - COMPARISON WITH FREQUENCY DATA OF OTHER EUROPEAN POPULATIONS [J].
CORBO, RM ;
SCACCHI, R ;
MUREDDU, L ;
MULAS, G ;
ALFANO, G .
ANNALS OF HUMAN GENETICS, 1995, 59 :197-209
[6]  
CORIA F, 1995, STROKE, V26, P2375
[7]   PREVALENCE OF APOLIPOPROTEIN-E PHENOTYPES IN ISCHEMIC CEREBROVASCULAR-DISEASE - A CASE-CONTROL STUDY [J].
COUDERC, R ;
MAHIEUX, F ;
BAILLEUL, S ;
FENELON, G ;
MARY, R ;
FERMANIAN, J .
STROKE, 1993, 24 (05) :661-664
[8]   INCIDENCE AND PROGNOSIS OF STROKE IN THE VALLE-DAOSTA, ITALY - 1ST-YEAR RESULTS OF A COMMUNITY-BASED STUDY [J].
DALESSANDRO, G ;
DIGIOVANNI, M ;
ROVEYAZ, L ;
IANNIZZI, L ;
COMPAGNONI, MP ;
BLANC, S ;
BOTTACCHI, E .
STROKE, 1992, 23 (12) :1712-1715
[9]  
DALLONGEVILLE J, 1992, J LIPID RES, V33, P447
[10]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21